GNE
Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
Also known as: GLCNE_HUMAN, IBM2, Uae1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y223
- Gene
- GNE
- Ensembl
- ENSG00000159921
- Chromosome
- 9
- Canonical length
- 722 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
The protein encoded by this gene is a bifunctional enzyme that initiates and regulates the biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. It is a rate-limiting enzyme in the sialic acid biosynthetic pathway. Sialic acid modification of cell surface molecules is crucial for their function in many biologic processes, including cell adhesion and signal transduction. Differential sialylation of cell surface molecules is also implicated in the tumorigenicity and metastatic behavior of malignant cells. Mutations in this gene are associated with sialuria, autosomal recessive inclusion body myopathy, and Nonaka myopathy. Alternative splicing of this gene results in transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
722 residues, UniProt reviewed canonical sequence.
>Q9Y223|GNE
1 MEKNGNNRKL RVCVATCNRA DYSKLAPIMF GIKTEPEFFE LDVVVLGSHL IDDYGNTYRM
61 IEQDDFDINT RLHTIVRGED EAAMVESVGL ALVKLPDVLN RLKPDIMIVH GDRFDALALA
121 TSAALMNIRI LHIEGGEVSG TIDDSIRHAI TKLAHYHVCC TRSAEQHLIS MCEDHDRILL
181 AGCPSYDKLL SAKNKDYMSI IRMWLGDDVK SKDYIVALQH PVTTDIKHSI KMFELTLDAL
241 ISFNKRTLVL FPNIDAGSKE MVRVMRKKGI EHHPNFRAVK HVPFDQFIQL VAHAGCMIGN
301 SSCGVREVGA FGTPVINLGT RQIGRETGEN VLHVRDADTQ DKILQALHLQ FGKQYPCSKI
361 YGDGNAVPRI LKFLKSIDLQ EPLQKKFCFP PVKENISQDI DHILETLSAL AVDLGGTNLR
421 VAIVSMKGEI VKKYTQFNPK TYEERINLIL QMCVEAAAEA VKLNCRILGV GISTGGRVNP
481 REGIVLHSTK LIQEWNSVDL RTPLSDTLHL PVWVDNDGNC AALAERKFGQ GKGLENFVTL
541 ITGTGIGGGI IHQHELIHGS SFCAAELGHL VVSLDGPDCS CGSHGCIEAY ASGMALQREA
601 KKLHDEDLLL VEGMSVPKDE AVGALHLIQA AKLGNAKAQS ILRTAGTALG LGVVNILHTM
661 NPSLVILSGV LASHYIHIVK DVIRQQALSS VQDVDVVVSD LVDPALLGAA SMVLDYTTRR
721 IYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GNE can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 85 nTPM
Expression across tissuesHPA
Tissue
- liver: 85 nTPM
- salivary gland: 52 nTPM
- rectum: 45 nTPM
- colon: 32 nTPM
- breast: 15 nTPM
- bone marrow: 15 nTPM
Single-cell type
- hepatocytes: 162 nCPM
- salivary acinar cells: 141 nCPM
- goblet cells: 139 nCPM
- epicardial cells: 114 nCPM
- respiratory secretory cells: 89 nCPM
- salivary duct cells: 82 nCPM
Immune cell
- naive CD8 T-cell: 1.2 nTPM
- naive CD4 T-cell: 1 nTPM
- memory CD4 T-cell: 0.9 nTPM
- naive B-cell: 0.9 nTPM
- memory CD8 T-cell: 0.8 nTPM
- non-classical monocyte: 0.8 nTPM
Brain region
- white matter: 26 nTPM
- cerebellum: 24 nTPM
- pons: 24 nTPM
- choroid plexus: 22 nTPM
- medulla oblongata: 21 nTPM
- midbrain: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GNE.
Disease | AllUniProt
Conditions GNE is implicated in, by any mechanism.
- Sialuria (SIALURIA) MIM:269921
- Nonaka myopathy (NM) MIM:605820
- Thrombocytopenia 12 with or without myopathy (THC12) MIM:620757
Disease | GeneticClinVar
223 pathogenic / likely-pathogenic of 1,239 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- GNE myopathy
- Sialuria
- Thrombocytopenia 12 with or without myopathy
- GNE-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.59
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- CMP-N-acetylneuraminate biosynthetic process
- N-acetylglucosamine biosynthetic process
- N-acetylneuraminate biosynthetic process
- UDP-N-acetylglucosamine metabolic process
Molecular functions
- ATP binding
- hydrolase activity, hydrolyzing O-glycosyl compounds
- metal ion binding
- N-acylmannosamine kinase activity
- UDP-N-acetylglucosamine 2-epimerase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATPase, nucleotide binding domain
- ROK family
- UDP-N-acetylglucosamine 2-epimerase domain
- Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
- ROK family
- UDP-N-acetylglucosamine 2-epimerase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GNE as an antibody target. Whether an autoantibody or antibody against GNE could matter depends on whether native GNE is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GNE is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GNE as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...